Representative image NEW DELHI: A study comparing homoeopathy with conventional primary care in infants has been retracted by the European Journal of Pediatrics, citing serious flaws in the study design.In a retraction note, the journal’s editor said concerns were raised after publication about the methodology of the randomised controlled trial, particularly the absence of blinding and placebo controls. A post-publication review found that these shortcomings could introduce “significant bias” in the interpretation of the data and conclusions.The editor said the flaws were fundamental and could not be corrected through an erratum, adding that there was no longer confidence in the reliability of the article.The study, published in 2024, examined homoeopathic treatment versus standard primary care in children during the first 24 months of life, a period requiring high ethical and scientific safeguards.According to the journal, the authors have been invited to submit a revised manuscript addressing the concerns. However, the retraction note states that the authors do not agree with the decision, a position conveyed by lead author Menachem Oberbaum.The paper involved authors from multiple institutions, including India, and had drawn attention because it compared an alternative system of medicine with conventional care in a vulnerable age group.Although the article remains available as an open-access publication, it is now clearly labelled as retracted. The publisher, Springer Nature, said it remains neutral on jurisdictional claims and institutional affiliations.The retraction underscores the need for rigorous trial design, especially in studies involving infants, where lack of blinding and placebo controls can strongly influence outcomes.End of ArticleFollow Us On Social MediaVideosBudget 2026: Defence Expert Flags Committed Liabilities, Calls For Battlefield TransparencyPak Defence Minister Khawaja Asif Admits Terror Rooted In Corruption, Vindicates India In ParliamentGold, Silver Under Pressure After Peaks: Should You Invest And Hold Precious Metals Or Sell Off?India Moves To Secure Chicken’s Neck As Underground Rail Project Targets Strategic Vulnerabilities’Exit India If…’: Supreme Court Sends Sharp Message To Meta Over WhatsApp Policy, Indian User Data’PM Modi Under Pressure From Trump’: Rahul Gandhi Claims As Trade Deal Debate Paralyses Lok SabhaIndia-US Trade Deal: US Tariff Cut Puts India Ahead Of China, Pakistan, Bangladesh In Trade Race‘I Will Not Bow Down To Hatred’:Uttarakhand Man Who Shielded Muslim Trader Becomes Social Media StarNDA MPs Felicitate PM Modi For India-US trade Deal At Parliamentary Party MeetingCongress Rounds On Govt As Trump Announces India‑US Trade Deal, Urges Full Disclosure To Parliament123Photostories’Vadh 2’, ‘Bhabhiji Ghar Par Hain’, ‘Devdas’ re-release: What to watch in cinemas this weekWaheeda Rehman birthday special: The journey that took her from Madras stages to a break opposite legendary actor NT Rama RaoArchana Puran Singh opens up about miscarriage, father’s sudden demise and more; says, “I felt abandoned by Parmeet during my pregnancy”Don’t Be Shy!’, ‘Alpha’, ‘Love & War’: A closer look at Alia Bhatt’s exciting slate ahead in 2026Before winter ends, cook these 10 cosy favourites one more time7 animals with extraordinary and rare face patterns on earthFuel switch cuts off again: Safety safeguard failure on Air India’s London–Bengaluru 787; what it revealsThese 5 countries have the most affordable housing and the reason is…Upcoming bikes in February 2026: 6 luxury bikes which are likely to hit the roads in February 2026’Dhurandhar’, Madras Cafe; Bollywood edge-of-the-seat spy thrillers inspired by real terror operations123Hot PicksBudget 2026Gold Silver PricesCigarette Prices HikeIndia US TradeIncome Tax CalculatorPublic holidays February 2026Bank Holidays februaryTop TrendingSuper Bowl HalftimeMLB Trade RumorsJarrell MillerTom BradyTampa Bay LightningNHL Trade RumorsDarnell NurseRyan ClarkSam BennettGold Riyadh Players Ranking
NEW DELHI: A study comparing homoeopathy with conventional primary care in infants has been retracted by the European Journal of Pediatrics, citing serious flaws in the study design.In a retraction note, the journal’s editor said concerns were raised after publication about the methodology of the randomised controlled trial, particularly the absence of blinding and placebo controls. A post-publication review found that these shortcomings could introduce “significant bias” in the interpretation of the data and conclusions.The editor said the flaws were fundamental and could not be corrected through an erratum, adding that there was no longer confidence in the reliability of the article.The study, published in 2024, examined homoeopathic treatment versus standard primary care in children during the first 24 months of life, a period requiring high ethical and scientific safeguards.According to the journal, the authors have been invited to submit a revised manuscript addressing the concerns. However, the retraction note states that the authors do not agree with the decision, a position conveyed by lead author Menachem Oberbaum.The paper involved authors from multiple institutions, including India, and had drawn attention because it compared an alternative system of medicine with conventional care in a vulnerable age group.Although the article remains available as an open-access publication, it is now clearly labelled as retracted. The publisher, Springer Nature, said it remains neutral on jurisdictional claims and institutional affiliations.The retraction underscores the need for rigorous trial design, especially in studies involving infants, where lack of blinding and placebo controls can strongly influence outcomes.
